Guidance addresses common challenges—from interoperability to network stability—to help healthcare organizations improve safety and efficiency in connected device operations.
AAMI has released TIR17:2024, updating guidance on ethylene oxide and new alternatives like chlorine dioxide and vaporized hydrogen peroxide.
"Bioburden reduction systems can play an important role in the ongoing efforts to help address shortages of FFRs,” says FDA's Binita Ashar, MD.
Guidance addresses common challenges—from interoperability to network stability—to help healthcare organizations improve safety and efficiency in connected device operations.